title: Augmentation of interleukin 2-activated cytotoxicity after treatment of cells with inhibitors of interferon production.
abstract: Low-density human lymphocytes cultured with recombinant interleukin 2 (rIL-2) generated a high level of interferon(s) (IFN). Consistently more IFN including IFN-tau was produced during the first 3 days of culture with rIL-2 than during the subsequent 4 days. That ability was mainly associated with mepacrine+ cells and was decreased by low concentrations of leucine methyl ester (Leu-O-Me) or ammonium chloride. Leu-O-Me was employed either for the pretreatment of cells before the culture or as the additive to culture medium. The decrease in IFN production after pretreatment was associated with enhanced rIL-2-activated cytotoxicity. Similarly, 1 mM of ammonium chloride or 1 mM of Leu-O-Me added to rIL-2 supplemented cultures for 3 days showed an association between inhibition of IFN-tau generation and increased activation of cytotoxic activity. Thus NK cells appear to regulate their own response to rIL-2 activation and the control mechanism seems to be associated with the ability of the cells to produce IFN(s) and possibly other cytokines.
authors.affiliation: Department of Immunology and Cell Biology, Forschungsinstitut Borstel, Federal Republic of Germany.
authors.forename: A
authors.initials: A
authors.lastname: Lange
authors.forename: R
authors.initials: R
authors.lastname: Fetting
authors.forename: B
authors.initials: B
authors.lastname: Jaźwiec
authors.forename: A
authors.initials: A
authors.lastname: Moniewska
authors.forename: J
authors.initials: J
authors.lastname: Ennen
authors.forename: M
authors.initials: M
authors.lastname: Ernst
authors.forename: H D
authors.initials: HD
authors.lastname: Flad
mesh_terms: D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D006801:Humans; D007372:Interferons / Q000096:biosynthesis*; D007376:Interleukin-2 / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D007930:Leucine / Q000031:analogs & derivatives* / Q000494:pharmacology; D008214:Lymphocytes / Q000378:metabolism; D011994:Recombinant Proteins / Q000494:pharmacology
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins; C030365:leucine methyl ester; D007372:Interferons; D007930:Leucine